NVS - Novartis AG

NYSE - NYSE Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5211.8B
Enterprise Value 3238.18B
Trailing P/E 17.29
Forward P/E 116.49
PEG Ratio (5 yr expected) 12.70
Price/Sales (ttm)3.96
Price/Book (mrq)4.49
Enterprise Value/Revenue 34.45
Enterprise Value/EBITDA 614.80

Trading Information

Stock Price History

Beta (3Y Monthly) 0.54
52-Week Change 341.21%
S&P500 52-Week Change 37.40%
52 Week High 393.65
52 Week Low 364.78
50-Day Moving Average 386.69
200-Day Moving Average 381.73

Share Statistics

Avg Vol (3 month) 32.56M
Avg Vol (10 day) 31.57M
Shares Outstanding 52.29B
Float 2.18B
% Held by Insiders 10.00%
% Held by Institutions 111.69%
Shares Short (Jun 14, 2019) 44.15M
Short Ratio (Jun 14, 2019) 41.96
Short % of Float (Jun 14, 2019) 4N/A
Short % of Shares Outstanding (Jun 14, 2019) 40.18%
Shares Short (prior month May 15, 2019) 42.73M

Dividends & Splits

Forward Annual Dividend Rate 42.83
Forward Annual Dividend Yield 43.07%
Trailing Annual Dividend Rate 32.89
Trailing Annual Dividend Yield 33.13%
5 Year Average Dividend Yield 43.26
Payout Ratio 453.07%
Dividend Date 3Mar 13, 2019
Ex-Dividend Date 4Mar 4, 2019
Last Split Factor (new per old) 21000/1116
Last Split Date 3Apr 9, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin 23.11%
Operating Margin (ttm)20.26%

Management Effectiveness

Return on Assets (ttm)4.95%
Return on Equity (ttm)21.11%

Income Statement

Revenue (ttm)53.46B
Revenue Per Share (ttm)23.07
Quarterly Revenue Growth (yoy)2.60%
Gross Profit (ttm)36.08B
EBITDA 16.1B
Net Income Avi to Common (ttm)12.51B
Diluted EPS (ttm)5.27
Quarterly Earnings Growth (yoy)-12.80%

Balance Sheet

Total Cash (mrq)7.05B
Total Cash Per Share (mrq)3.03
Total Debt (mrq)30.59B
Total Debt/Equity (mrq)64.66
Current Ratio (mrq)0.93
Book Value Per Share (mrq)20.33

Cash Flow Statement

Operating Cash Flow (ttm)13.67B
Levered Free Cash Flow (ttm)22.3B